Quantcast

Latest Securities Stories

2014-09-19 20:22:55

AUSTIN, Texas, Sept. 19, 2014 /PRNewswire/ -- Crossroads Systems, Inc. (NASDAQ: CRDS), a global provider of data archive solutions, announced today the filing of a Registration Statement on Form S-1 with the Securities and Exchange Commission in connection with a proposed public offering, on a best-efforts basis, of up to $12,000,000 aggregate amount of Series H Cumulative Perpetual Preferred Stock, liquidation preference of $25.00 per share, and warrants to purchase its Common...

2014-09-19 20:21:08

DENVER, Sept. 19, 2014 /PRNewswire/ -- BIOFUEL ENERGY CORP. (NASDAQ:BIOF) (the "Company") today made an announcement relating to the Company's rights offering. On or about September 22, 2014, the Company will distribute, at no charge, to the holders of its common stock transferable subscription rights to purchase common stock. Each holder of shares of Company common stock as of 5:00 p.m., New York City time, on September 15, 2014 (the "Record Date") will receive one subscription...

2014-09-19 08:25:59

SAN DIEGO, Sept. 19, 2014 /PRNewswire/ -- Lpath, Inc. (NASDAQ: LPTN), the industry leader in bioactive lipid-targeted therapeutics, announced today that it has entered into definitive agreements to sell 3,605,042 registered shares of common stock and 3,605,042 unregistered warrants in a registered direct offering. The combined purchase price for one registered share of common stock and one unregistered warrant to purchase one unregistered share of common stock will be $3.475. The...

2014-09-18 20:23:06

KANSAS CITY, Kan., Sept. 18, 2014 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals, today announced the full exercise of the underwriters' option to purchase 675,000 additional shares of common stock in connection with the company's previously announced public offering of 4,500,000 shares of common stock. All of the shares are being...

2014-09-18 08:30:10

SEATTLE, Sept. 18, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY) today announced the pricing of previously announced concurrent but separate underwritten offerings of 10,000,000 shares of its Common Stock at a price to the public of $2.00 per share, for expected gross proceeds of $20 million and 10,000 shares of its Series A Convertible Preferred Stock at a price to the public of $2,000.00 per share, for expected gross proceeds of $20 million. Each share of Series A Convertible...

2014-09-17 16:27:34

SEATTLE, WA, Sept. 17, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY) today announced that it intends to offer and sell shares of its Common Stock and Series A Convertible Preferred Stock in separate but concurrent underwritten public offerings. The Series A Convertible Preferred Stock is non-voting and convertible into shares of Oncothyreon Common Stock, provided that conversion will be prohibited if, as a result, the holder and its affiliates would beneficially own more than...

2014-09-17 12:22:20

HOUSTON and PITTSBURGH, Sept. 17, 2014 /PRNewswire/ -- CONE Midstream Partners LP, a Delaware limited partnership ("CONE Midstream Partners") formed by CONSOL Energy Inc. (NYSE: CNX) and Noble Energy, Inc. (NYSE: NBL), announced today that it has launched its initial public offering of 17,500,000 common units representing limited partner interests. The common units are expected to trade on the New York Stock Exchange under the ticker symbol "CNNX." The underwriters of the offering...

2014-09-17 08:37:38

SHELTON, Conn., Sept. 17, 2014 /PRNewswire/ -- Nxt-ID, Inc. (Nasdaq: NXTD and NXTDW) ("Nxt-ID" or the "Company") announced today that it has closed the previously announced underwritten public offering of its common stock and warrants. The Company offered 2,127,273 shares of common stock and 2,127,273 warrants to purchase shares of common stock, at a combined price to the public of $2.75 per share and related warrant. The warrants are exercisable for a period of five years beginning...

2014-09-17 08:31:10

KANSAS CITY, Kan., Sept. 17, 2014 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on licensing, developing and commercializing innovative biopharmaceutical products for companion animals, today announced the pricing of its public offering of 4,500,000 shares of its common stock at a price to the public of $9.25 per share. Aratana has granted the underwriters a 30-day option to purchase up to an additional 675,000 shares of its common...

2014-09-16 16:23:46

BATON ROUGE, La., Sept. 16, 2014 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB) today announced that it has set a date for a special meeting of its shareholders to consider and vote on the issuance of Albemarle shares of common stock in connection with its proposed acquisition of Rockwood Holdings, Inc. (NYSE:ROC). The Albemarle special meeting will be held on Friday, November 14, 2014 at 8 a.m. Central Standard Time at the company's headquarters located at 451 Florida Boulevard,...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related